H-Arg-OtBu

H-Arg-OtBu is an arginine-derived amino acid ester in which the α-amino group is present as a free amino functionality and the α-carboxyl group is masked as a tert-butyl ester (OtBu). The side chain contains a stereochemically defined guanidinium functionality that is strongly basic and can form salt bridges, hydrogen-bond networks, and ionic interactions under peptide-coupling and deprotection conditions. The tert-butyl ester provides acid-labile protection of the carboxylate, enabling controlled conversion to the corresponding carboxylic acid or activation for peptide bond formation. The combination of a free amino group with an ester-protected carboxyl group makes H-Arg-OtBu a practical chiral amino acid intermediate for assembling arginine-containing sequences and for downstream derivatization of the C-terminal functionality.

1. Peptide Synthesis

H-Arg-OtBu supports peptide building workflows where C-terminal ester activation and subsequent coupling can be used to construct arginine-containing fragments. The guanidinium side chain of the arginine scaffold participates in ionic recognition during coupling and can require compatibility with base/acid conditions used for ester activation and peptide bond formation. The OtBu ester masking strategy allows staged handling of the carboxylate, enabling transformation to an acid form for activation or to a protected carboxyl equivalent for fragment coupling. The resulting arginine-containing intermediates can be carried forward into protected peptide assembly and purification workflows, aligning with standard amino acid chemistry practices for peptide science.

2. Side-Chain Functionalization

H-Arg-OtBu can be applied in chemical biology and synthetic organic chemistry to introduce functional modifications at the guanidinium-bearing side chain while retaining the ester-protected backbone for controlled reactivity. The strongly basic guanidine motif can be targeted for derivatization strategies that tune charge density, hydrogen-bonding capacity, or conjugation handles, while the tert-butyl ester can be maintained during selective side-chain transformations. The free amino group enables additional derivatization or orthogonal protection planning when preparing multifunctional arginine analogs. Downstream conversion of the OtBu ester to a carboxylic acid supports incorporation into larger scaffolds, including peptidomimetic constructs and charged molecular probes.

3. Chiral Amino Acid Intermediate

H-Arg-OtBu functions as a chiral amino acid intermediate for stereoselective synthesis routes that require arginine's defined stereochemistry at the α-carbon. The protected carboxyl group as OtBu supports process-compatible handling by reducing premature hydrolysis and by enabling controlled deprotection to regenerate the carboxylate for activation steps. The presence of the free amino group allows planning of N-protection strategies to match the coupling chemistry used in peptide construction or to prepare amino acid derivatives for orthogonal functionalization. The guanidinium side chain's ionic character also influences salt formation and purification behavior, making the intermediate suitable for stepwise construction of arginine-bearing building blocks and downstream fine chemical synthesis.

4. Bioconjugation Chemistry

H-Arg-OtBu can be employed in bioconjugation and biomolecule modification workflows where arginine's guanidinium group is used to drive electrostatic interactions with negatively charged biomolecular surfaces. The OtBu ester can be used as a temporary C-terminal protection element to control hydrolytic stability during conjugation planning and to enable later conversion to an activated acid form for coupling to biomolecule-reactive scaffolds. The free amino functionality can be incorporated into conjugation design by selecting orthogonal protection or by enabling formation of amide linkages after appropriate activation. The resulting arginine-containing conjugates and intermediates can serve in chemical biology studies that probe binding, trafficking, or recognition mechanisms mediated by cationic guanidinium interactions.

5. Pharmaceutical Intermediate Preparation

H-Arg-OtBu is suitable for pharmaceutical intermediate preparation in synthetic routes that require arginine-containing fragments with controlled C-terminal protection. The tert-butyl ester provides an acid-labile handle for converting to the corresponding carboxylic acid during manufacturing steps, supporting activation to carboxyl derivatives used in peptide-like bond formation. The guanidinium side chain can be maintained through multiple transformations by selecting compatible conditions, enabling incorporation into larger drug-like molecules, peptidomimetics, or polar fragment libraries. The compound's amino acid structure and protected carboxyl functionality align with industrial chemical manufacturing needs for reliable intermediate handling, predictable functional group interconversion, and scalable synthesis planning.

1. Myotropic activity and immunolocalization of selected neuropeptides of the burying beetle Nicrophorus vespilloides (Coleoptera: Silphidae)

2. C-peptide and its C-terminal fragments improve erythrocyte deformability in type 1 diabetes patients

3. GLP-1, exendin-4 and C-peptide regulate pancreatic islet microcirculation, insulin secretion and glucose tolerance in rats

4. P-selectin and Complement’s Role in a Neonatal Model of Germinal Matrix Hemorrhage-Induced Secondary Injury

5. Extended exenatide administration enhances lipid metabolism and exacerbates pancreatic injury in mice on a high fat, high carbohydrate diet